Madrigal Pharmaceuticals (MDGL) Non-Current Assets (2019 - 2025)
Historic Non-Current Assets for Madrigal Pharmaceuticals (MDGL) over the last 14 years, with Q3 2025 value amounting to $15.8 million.
- Madrigal Pharmaceuticals' Non-Current Assets rose 6436.09% to $15.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year increase of 5646.41%. This contributed to the annual value of $9.3 million for FY2024, which is 18536.44% up from last year.
- As of Q3 2025, Madrigal Pharmaceuticals' Non-Current Assets stood at $15.8 million, which was up 6436.09% from $12.0 million recorded in Q2 2025.
- In the past 5 years, Madrigal Pharmaceuticals' Non-Current Assets ranged from a high of $15.8 million in Q3 2025 and a low of $866000.0 during Q2 2023
- Its 5-year average for Non-Current Assets is $4.9 million, with a median of $1.9 million in 2021.
- Per our database at Business Quant, Madrigal Pharmaceuticals' Non-Current Assets plummeted by 5308.78% in 2023 and then skyrocketed by 83083.14% in 2024.
- Quarter analysis of 5 years shows Madrigal Pharmaceuticals' Non-Current Assets stood at $1.6 million in 2021, then dropped by 27.0% to $1.2 million in 2022, then skyrocketed by 171.49% to $3.3 million in 2023, then soared by 185.36% to $9.3 million in 2024, then surged by 69.28% to $15.8 million in 2025.
- Its Non-Current Assets stands at $15.8 million for Q3 2025, versus $12.0 million for Q2 2025 and $8.6 million for Q1 2025.